Talis Biomedical

Talis Biomedical Enterprise Value

Delisted

The Enterprise Value (EV) of Talis Biomedical (TLIS) as of Oct 17, 2026 is -71.56 M USD. In the previous year, Enterprise Value (EV) was -125.02 M USD — a change of -42.76% (higher).

Enterprise Value

-71.56 MUSD

YoY

-42.76%

Last updated:

Enterprise Value (EV) of Talis Biomedical is 2023 -71.56 M USD. Enterprise Value (EV) of Talis Biomedical was 2022 -125.02 M USD. It decreases by -42.76% higher compared to the previous year.

The Talis Biomedical Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
-1.72 M USD
Jan 1, 2019
-16.43 M USD
Jan 1, 2020
-133.31 M USD
Jan 1, 2021
-227.38 M USD
Jan 1, 2022
-125.02 M USD
Jan 1, 2023
-71.56 M USD
The Talis Biomedical Enterprise Value history
YEAREnterprise ValueYoY
-71.56 MUSD-42.76%
-125.02 MUSD-45.02%
-227.38 MUSD+70.56%
-133.31 MUSD+711.20%
-16.43 MUSD+852.70%
-1.72 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Talis Biomedical Stock analysis

What does Talis Biomedical do? Talis Biomedical Corp, headquartered in Redwood City, California, operates in the Health Care Equipment & Supplies sector. The company, listed on 12 February 2021, employs 102 full-time staff. It develops and commercializes point-of-care molecular diagnostic products, focusing on the Talis One system—a cloud-enabled platform combining a compact instrument, single-use cartridges, and software for central laboratory accuracy. The firm targets infectious disease testing, including respiratory infections, women's health, and STIs, with assays for influenza A/B and a respiratory panel integrating COVID-19 testing. Talis Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Talis Biomedical stock

Enterprise Value (EV) of Talis Biomedical is -71.56 M USD in 2023.

Enterprise Value (EV) of Talis Biomedical changed from -125.02 M USD to -71.56 M USD, representing a -42.76% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Talis Biomedical since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Talis Biomedical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Talis Biomedical

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Talis Biomedical